 Researchers reported missing functionalities in the earlier versions of tranSMART (version 16.2 and before), which restricted the capabilities of the tool and opportunities for research.In response, tranSMART Foundation brought together four leading pharmaceutical companies – Pfizer, Sanofi, Abbvie and Roche – together in October 2016 to help sponsor a joint project to develop the new functionality in a coherent way and improve tranSMART.The Hyve BV was the IT company responsible for the execution of the tranSMART 17.1 development project.